09 Feb. 2010
WILMINGTON, N.C. (February 9, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced its global central lab operations in Singapore has earned accreditation by the College of American Pathologists (CAP), validating its ability to deliver high-quality, reliable data that meet the highest standard of excellence in enhancing patient safety and speeding drug development.
The Singapore facility is PPD's fourth central lab to achieve accreditation by the CAP Laboratory Accreditation Program. This internationally recognized program uses rigorous accreditation standards to help laboratories improve patient care by providing quality laboratory services. A multidisciplinary team of practicing lab professionals inspected the facility, examining staff qualifications, laboratory equipment and facilities, safety programs and records, and overall management of laboratory operations.
"Achieving CAP accreditation six weeks after opening our Singapore facility demonstrates the expertise of our scientists and our commitment to excellence," said Steve Lobel, Ph.D., vice president of PPD's global central laboratory operations. "Within weeks of opening our laboratory, we added new assay technologies and are supporting high-level testing to expand upon the services we offer our clients."
PPD opened its Singapore central lab last year in response to growing client demand in Southeast Asia. PPD also operates central labs in Highland Heights, Ky., Beijing, China, and Brussels, Belgium.